When linking vascular PSMA expression to tumor metabolism and survival, these data seem to reflect previous findings showing that IDH mutation in gliomas leads to a decrease in HIF1A activation and, consequently, to downstream inhibition of hypoxia, as well as vasculo- and angiogenesis related signaling [49]. This evidence concerns the gene FOLH1 and central nervous system cancer.